Drug Interaction Report

Sertraline and Dihydroergotamine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Dihydroergotamine

Brekiya Migranal Trudhesa
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 18 are rated moderate — including this one.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Taking sertraline with dihydroergotamine may add to serotonin activity and, in theory, cause weakness, overactive reflexes, or poor coordination. Keep taking both as prescribed, watch for these symptoms, and report them to your care team.

You've been prescribed sertraline (an antidepressant) along with dihydroergotamine, a medicine used to treat migraines. Both of these can affect serotonin, a chemical messenger in your body. When taken together, there is a possible risk of side effects like muscle weakness, overactive reflexes, and trouble with coordination.

Please know this is considered a theoretical risk, meaning it hasn't been strongly proven, and many people take these safely. Keep taking both as prescribed, but let your pharmacist or doctor know you're on both so they can keep an eye on you. If you notice new weakness, jerky reflexes, or feeling unsteady, reach out to them.

Interaction: Coadministration of dihydroergotamine (an ergot-derivative serotonergic agonist) with the SSRI sertraline may additively increase serotonergic activity, raising the risk of weakness, hyperreflexia, and incoordination (features overlapping serotonin toxicity).

  • Direction: Additive serotonergic effect; neither agent is a prodrug affecting this pathway.
  • Mechanism: Unknown/presumed pharmacodynamic.
  • Onset: Rapid.
  • Evidence: Theoretical; severity moderate.
  • Management: Monitor for neuromuscular and autonomic serotonergic signs. Dose/therapy may be individualized; consider alternatives if symptoms emerge.
Onset
rapid
Evidence
theoretical
Severity
Moderate

What happens

An increased risk of weakness, hyperreflexia and incoordination

Interaction Deep Dive

Giving dihydroergotamine together with selective serotonin reuptake inhibitors may heighten the likelihood of incoordination, hyperreflexia and weakness123.

Why it happens (mechanism)

Unknown

How to manage this interaction

This combination can be used with care, and your care team can manage it.

  • Keep taking both as prescribed unless your prescriber tells you otherwise.
  • Your team may monitor you more closely for symptoms, especially since effects can appear quickly.
  • Watch for new muscle weakness, jerky or overactive reflexes, or trouble with coordination or balance, and report these promptly.
  • If symptoms occur, your team may adjust therapy or consider an alternative migraine treatment.

Tell your pharmacist and doctor you take both so they can tailor the plan to you.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) On rare occasions, the concurrent use of 5-HT1 agonists (for example, dihydroergotamine) with selective serotonin reuptake inhibitors (SSRIs) has been associated with reports of weakness, hyperreflexia, and incoordination 123.

Common questions

Can I take Sertraline and Dihydroergotamine together?

Taking sertraline with dihydroergotamine may add to serotonin activity and, in theory, cause weakness, overactive reflexes, or poor coordination. Keep taking both as prescribed, watch for these symptoms, and report them to your care team. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Dihydroergotamine interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How is the Sertraline and Dihydroergotamine interaction managed?

This combination can be used with care, and your care team can manage it. Keep taking both as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for symptoms, especially since effects can appear quickly. Watch for new muscle weakness, jerky or overactive reflexes, or trouble with coordination or balance, and report these promptly. If symptoms occur, your… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Dihydroergotamine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (3)

  1. Product Information: ATZUMI(R) nasal powder, dihydroergotamine nasal powder. Satsuma Pharmaceuticals (per Manufacturer), Durham, NC, 2025. DailyMed
  2. Product Information: BREKIYA(R) subcutaneous injection, dihydroergotamine mesylate subcutaneous injection. Amneal Pharmaceuticals (Per Manufacturer), Bridgewater, NJ, 2025. DailyMed
  3. Product Information: TRUDHESA(TM) nasal spray, dihydroergotamine mesylate nasal spray. Impel NeuroPharma Inc (per DailyMed), Seattle, WA, 2021. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.